USPTO serial 97401062
DURECT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 28, 2024
- Examiner
- FLOWERS, JAY K
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DURECT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Cupertino, CA, US
MEDICIS PHARMACEUTICAL CORPORATION
BRIDGEWATER, NJ, US
Other trademarks owned by MEDICIS PHARMACEUTICAL CORPORATION
Cupertino, CA, US
Cupertino, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeremy Blackowicz
Jeremy Blackowicz Bausch Health Companies400 Somerset Corporate Blvd.Bridgewater, NJ 08807United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, diseases and disorders of the endocrine system, inflammatory diseases and disorders, autoimmune diseases and disorders, cancer, neurological diseases and disorders, central nervous system diseases and disorders, acute organ injury, epigenetic diseases and disorders, and DNA methyltransferase (DNMT)-associated diseases and disorders | ACTIVE | Dec 7, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Durect Corporation
- Other trademarks owned by MEDICIS PHARMACEUTICAL CORPORATION
- Other trademarks owned by Durect Corporation
- Other trademarks owned by Durect Corporation
- Other trademarks in Class 005
- Similar marks named DURECT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 22, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Sep 23, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 23, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 23, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 23, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 23, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 17, 2024 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Jun 17, 2024 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Jun 11, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 28, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 28, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 23, 2024 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED | — |
| Apr 23, 2024 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Apr 23, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Apr 22, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 3, 2024 | IUAF | USE AMENDMENT FILED | — |
| Apr 3, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Apr 3, 2024 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jan 19, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 17, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 17, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 17, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 18, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 23, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 23, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 3, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 18, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 18, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 18, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 18, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 18, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 2, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 2, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 2, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 27, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 14, 2022 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| May 13, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 12, 2022 | NWAP | NEW APPLICATION ENTERED | — |